Login
$NSRX
$2.66 +$0.00 (0.0%) After hours

Company Executives

Officer Age In this role Source
Dan Teleman Also a director
Chief Executive Officer and Director
53 Not stated
Brendan P. O'Grady
Chief Executive Officer
Title from the Form 4 dated Oct 8, 2026
Not stated Not stated
Eyal Rubin
Chief Financial Officer and Executive Vice President
50 Since 2025
1 year
Oren Elmaliah
Interim CFO
Title from the Form 3 dated Sep 19, 2026
Not stated Not stated
Dr. Dalia Megiddo Also a director
Co-Founder, Director, Chief Development Officer and Chief Medical Officer
74 Not stated
Udi Gilboa Also a director
Co-Founder and Executive Chairman of the Board of Directors
59 Not stated

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the 20-F annual report

Directors
7
serving now
Independent
2 of 2
stated in the proxy; 5 not stated
Average tenure
7.0 years
from year joined
CEO also chairs the board
No
Udi Gilboa
Director Age On board Independent Committees Pay Source
Udi Gilboa
59 Not stated Not stated None stated Not stated
Dan Teleman
53 2025
1 year
Not stated None stated Paid as CEO
Dr. Dalia Megiddo
74 2019
7 years
Not stated None stated Not stated
Dr. Ronnie Hershman
67 2020
6 years
Independent
Compensation Committee
Not stated
David Silberman
42 Not stated Independent
Audit Committee and Financial Statement Examination Committee
Not stated
Dr. Sharon Shacham
55 Not stated Not stated
Compensation Committee Audit Committee and Financial Statement Examination Committee
Not stated
Isaac Israel
47 2012
14 years
Not stated
Compensation Committee Audit Committee and Financial Statement Examination Committee
Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No proxy statement on record

Related-party transactions come from the company’s proxy statement. Nasus Pharma Ltd has not filed one with the SEC.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support